SVP of Finance CFO of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Hineline Lawrence J., sells 10,442 shares worth $409,625
According to Intra-Cellular Therapies, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:05 PM, company SVP of Finance CFO, Hineline Lawrence J. disclosed selling 10,442 shares at a cost of $39.23. At the time of this transaction (Feb 19), this trade was worth $409,625 in total. As of Feb 19, Hineline Lawrence J. now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) SVP of Finance CFO, Hineline Lawrence J., we have the following information:
- SEC Form 4 filing: Jan 11: Sold 19,638 shares at the rate of $32.02 per share. Total worth of this trade was $628,769. Total number of shares owned as of Jan 11 were 0
- SEC Form 4 filing: Jan 04: Sold 15,810 shares at the rate of $31.31 per share. Total worth of this trade was $495,008. Total number of shares owned as of Jan 04 were 350
- SEC Form 4 filing: Nov 11: Sold 28,034 shares at the rate of $25.41 per share. Total worth of this trade was $712,344. Total number of shares owned as of Nov 11 were 0
Posted by
George Daniels
on Monday February 22 2021, 11:55 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
